Douglas E. Ferguson
General Counsel at Poseidon Medical, Inc.
Profile
Douglas E.
Ferguson is currently the Vice President-Regulatory & Quality at Poseidon Medical, Inc. Prior to this, he held positions as the Director-Regulatory Affairs at Becton, Dickinson & Co., Regulatory Affairs Specialist at C.
R.
Bard, Inc. (New Jersey), and Vice President-Regulatory Affairs at Boston Scientific Corp.
He completed his undergraduate degree at The Johns Hopkins University and his graduate degree at The University of Alabama at Birmingham.
Douglas E. Ferguson active positions
Companies | Position | Start |
---|---|---|
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | General Counsel | - |
Former positions of Douglas E. Ferguson
Companies | Position | End |
---|---|---|
BOSTON SCIENTIFIC CORPORATION | General Counsel | - |
C.R. BARD | Corporate Officer/Principal | - |
BECTON, DICKINSON AND COMPANY | General Counsel | - |
Training of Douglas E. Ferguson
The Johns Hopkins University | Undergraduate Degree |
The University of Alabama at Birmingham | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BECTON, DICKINSON AND COMPANY | Health Technology |
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Private companies | 2 |
---|---|
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | Health Technology |
C. R. Bard, Inc. (New Jersey)
C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
- Stock Market
- Insiders
- Douglas E. Ferguson